
Gero
Operator of a preclinical-stage biotechnology company intended to create therapeutics against the root causes of age-related and other chronic diseases. The company uses AI to create disease phenotype...
Valuation
$0
Share Price
N/A
Total Raised
$8.2M
Last Round
N/A